Molecular analysis of 1p32 genetic involvement in pediatric T-cell non- Hodgkin's lymphoma

Haematologica

Volumn 84, Issue 2, 1999, Pages 110-113

  Perotti, Daniela ^a   Pettenella, Francesca ^b   Luksch, Roberto ^a   Giardini, Roberto ^a   Gambirasio, Felicita ^a   Ferrari, Daniela ^a   Fossati Bellani, Franca ^a   Biondi, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Childhood tumors; Genetics; Loss of heterozygosity; Non Hodgkin's lymphoma; TAL1

Indexed keywords

DNA; GALLIUM; TECHNETIUM 99M;

ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; CHILD; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; ECHOGRAPHY; FEMALE; GENE; GENE DELETION; GENE MAPPING; GENE REARRANGEMENT; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MICROSATELLITE INSTABILITY; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; T CELL LYMPHOMA; THORAX RADIOGRAPHY;

ADOLESCENT; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; GENE DELETION; GENE REARRANGEMENT; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHOMA, T-CELL; MALE; MICROSATELLITE REPEATS;

EID: 0032880197     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Reinherz EL, Nadler M, Sallin SE, Schlossman SF. Subset derivation of T-cell acute lymphoblastic leukemia in man. J Clin Invest 1979; 64:392-7.
2. Roper M, Crist WM, Metzgar R, et al. Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. Blood 1983; 61:830-7.
3. Crist WM, Shuster JJ, Falleta J, et al. Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group study. Blood 1988; 72: 1891-7.
4. Bernard A, Boumsell L, Patte C, Lemerle J. Leukemia versus lymphoma in children. A worthless question? Med Pediatr Oncol 1986; 14:148-57.
5. Offit K Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RSK. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chrom Cancer 1991; 3:189-201.
6. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993; 81:2237-51.
7. Chen Q, Cheng J-T, Tsai L-H, et al. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 1990; 9:415-24.
8. Chen Q, Yang CY-C, Tsan JT, et al. Coding sequences of the TAL1 gene are disrupted by chromosome translocation in human T-cell leukemia. J Exp Med 1990; 172:1403-8.
9. Bernard O, Guglielmi P, Jonveaux P, et al. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromos Cancer 1990; 1:194-208.
10. Finger LR, Kagan J, Christopher G, et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 1989; 86:5039-43.
11. Begley CG, Aplan PD, Denning SM, Haynes BF, Waldmann TA, Kirsch IR. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci USA 1989; 86:10128-32.
12. Carroll AJ, Crist WM, Link MP, et al. The t(1;14) (p34;q11) is non-random and restricted to T-cell acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood 1990; 76:1220-4.
13. Brown L, Cheng J-T, Chen Q, et al. Site-specific recombination of the TAL1 gene is a common occurrence in human T cell leukemia. EMBO J 1990; 9:3343-51.
14. Bernard O, Lecointe N, Jonveaux P, et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the TAL1 gene. Oncogene 1991; 6:1477-88.
15. Aplan PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 1992; 79:1327-33.
16. Bash RO, Crist WM, Shuster JJ, et al. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood 1993; 81:2110-7.
17. Breit TM, Mol EJ, Wolvers-Tettero IL, Ludwig W-D, van Wering ER, van Dongen JJM. Site-specific deletions involving the TAL1 and sil genes are restricted to cells of the T cell receptor α/β lineage: T cell receptor δ gene deletion mechanism affects multiple genes. J Exp Med 1993; 177:965-77.
18. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988; i:292-3.
19. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification. Lancet 1988; i:603.
20. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
21. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphoma: dissimilarities from lymphomas in adults. Semin Oncol 1980; 7:332-9.
22. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
23. Iolascon A, Faienza MF, Coppola B, et al. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene. Leukemia 1997; 11:359-63.
24. Weissenbach J, Gyapay G, Dib C, et al. A second generation linkage map of the human genome. Nature 1992; 359:794-801.
25. Watkins C, Warne D, Kelsell D, Beckmann J, Nyberg K, Spurr N. The use of PCR and ethidium bromide staining to detect length variation in short repeat units. Technique 1991; 3:175-8.
26. Biondi A, Champagne E, Rossi V, et al. T-cell receptor delta gene rearrangement in childhood T-cell acute lymphoblastic leukemia. Blood 1989; 73:2133-8.
27. Kurtzberg J, Waldmann TA, Davey MP, et al. CD7+, CD4-, CDS-acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989; 73:381-90.
28. Kikuchi A, Hayashi Y, Kobayashi S, et al. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma. Leukemia 1993; 7:933-8.
29. Neri A, Fracchiolla NS, Roscetti E, et al. Molecular analysis of cutaneous B- and T-cell lymphomas. Blood 1995; 86:3160-72.